5 Neuroendocrine Tumors Clinical Trials in Indianapolis, IN (2026)

Q: How do I join a clinical trial in Indianapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you.

Recruiting Neuroendocrine Tumors Studies in Indianapolis

NCT02450851Recruiting

Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

Without an explanation for severe and sometimes life-threatening symptoms, patients and their families are left in a state of unknown. Many individuals find themselves being passed from physician to p...

Indianapolis, IN20,000 participantsNational Human Genome Research Institute (NHGRI)

View Study Details

NCT07819435Recruiting

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

The study is designed to validate efficacy and long term safety of PP405....

Indianapolis, INPHASE2600 participantsPelage Pharmaceuticals, Inc.

View Study Details

NCT06539507Recruiting

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

This is a first-in-human, Phase 1/1b, 4-part study that includes the evaluation of safety, tolerability, pharmacokinetics (PK), and immunogenicity of BCX17725 when administered via single and multiple...

Indianapolis, INPHASE178 participantsBioCryst Pharmaceuticals

View Study Details

NCT05789056Recruiting

Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome...

Indianapolis, INPHASE220 participantsQuoin Pharmaceuticals

View Study Details

NCT07538583Recruiting

Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

This is a multicenter, open-label study to evaluate the safety, tolerability, and efficacy of 4% QRX003 lotion applied twice daily (BID) for 12 weeks to Netherton syndrome (NS) diseased skin in all af...

Indianapolis, INPHASE216 participantsQuoin Pharmaceuticals

View Study Details

About Neuroendocrine Tumors Clinical Trials in Indianapolis

Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.

There are currently 5 neuroendocrine tumors clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 20,714 participants. Research is being sponsored by National Human Genome Research Institute (NHGRI), Pelage Pharmaceuticals, Inc., BioCryst Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neuroendocrine Tumors Clinical Trials in Indianapolis — FAQ

Are there neuroendocrine tumors clinical trials in Indianapolis?

Yes, there are 5 neuroendocrine tumors clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What neuroendocrine tumors treatments are being tested?

The 5 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.

Data updated October 3, 2026 from ClinicalTrials.gov